DEXLANSOPRAZOLE
Manufacturer: Bryant Ranch Prepack
Score: 141.0
Dexlansoprazole delayed release is a proton pump inhibitor used for the healing of all grades of erosive esophagitis, maintenance of healed erosive esophagitis, and treatment of symptomatic non-erosive gastroesophageal reflux disease. The recommended dosage is 30-60 mg once daily for up to 8 weeks. Important safety information includes contraindications for patients with known hypersensitivity to any component of the formulation and patients receiving rilpivirine-containing products. Adverse reactions may include diarrhea, abdominal pain, nausea, and vomiting. Special population considerations include use during pregnancy, pediatric use, and geriatric use.
Contraindicated in patients with known hypersensitivity to any component of the formulation and patients receiving rilpivirine-containing products
Dose adjustment is recommended for patients with moderate hepatic impairment
60 mg once daily for up to 8 weeks
30-60 mg once daily for up to 8 weeks (12-17 years old)
30 mg once daily for up to 6 months
30 mg once daily for up to 16 weeks (12-17 years old)
30 mg once daily for 4 weeks
30 mg once daily for 4 weeks (12-17 years old)